Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Tumors of the Central Nervous System, Volume 8 - Tumors of the Central Nervous System

Astrocytoma, Medulloblastoma, Retinoblastoma, Chordoma, Craniopharyngioma, Oligodendroglioma, and Ependymoma - Previously published in hardcover
BuchKartoniert, Paperback
347 Seiten
Englisch
Springer Netherlandserschienen am23.08.2016Softcover reprint of the original 1st ed. 2012
With much more besides, including discussion of the molecular mechanisms that result in resistance to chemotherapy in medulloblastoma, this volume and its companions have a positive role to play in inspiring a new generation of researchers to design new drugs that are better targeted-and thus more effective.mehr
Verfügbare Formate
BuchKartoniert, Paperback
EUR213,99
BuchGebunden
EUR213,99

Produkt

KlappentextWith much more besides, including discussion of the molecular mechanisms that result in resistance to chemotherapy in medulloblastoma, this volume and its companions have a positive role to play in inspiring a new generation of researchers to design new drugs that are better targeted-and thus more effective.
ZusammenfassungThe eighth in the essential Springer series on CNS neoplasms, this volume deals with seven distinct types in detail. Expert contributors share their wisdom, covering new diagnostic and therapeutic techniques, and providing insights into hot research topics.

Inhalt/Kritik

Inhaltsverzeichnis
Preface. I Astrocytoma.-1. Astrocytoma cell line: role of brain natriuretic peptide.-2 Malignant brain astrocytomas: extent of resection affects survival. II Medulloblastoma.-3 Medulloblastoma: classification (a review).-4 Medulloblastomas: clinically important microrna genes.-5 Medulloblastoma: role of otx2 transcription factors.-6 Molecular mechanisms of chemoresistance in medulloblastoma.-7 Extraneural metastasis in medulloblastoma.-8 Medulloblastoma: therapy with bortezomib/tumor necrosis factor-related apoptosis-inducing ligand.-9 Standard-risk medulloblastoma: hyperfractionated radiotherapy.III Retinoblastoma.-10 Retinoma and retinoblastoma: genomic hybridisation.-11. cell cycle control by ataxia telangiectasia mutated protein through regulating retinoblastoma protein phosphorylation.-12. Role of survivin in retinoblastoma: diagnosis and prognosis.-13 Retinoblastoma: the role of epigenetics.-14 Retinoblastoma: disease, diagnosis, therapy and management.-15 Long-term survivors of retinoblastoma: risk of increased second malignancy.-16 New cancers among long-term survivors of retinoblastoma. IV chordoma.-17 Chordoma: role of cam5.2.-18 Chordomas and chondrosarcomas: treatment with particle radiotherapy.-19 Skull base chordomas: endonasal endoscopic transclival approach. V Craniopharyngioma.-20 Craniopharyngioma: comparison between supra-orbital versus endonasal keyhole approaches.-21 The expanded endoscopic endonasal approach for primary and recurrent craniopharyngiomas.-22 Craniopharyngioma: the role of radiation.-23. cystic craniopharyngiomas: intratumoral bleomycin therapy. VI Oligodendroglioma.-24 Anaplastic oligodendroglioma metastasized to extraneural sites.-25 Recurrent oligodendroglioma: treatment with bevacizumab. VII Ependymoma.-26 Ependymoma: an overview.-27 Ependymomas: prognosis based on genetic aberrations.-28 Aberrant dna methylation in ependymomas.-29 Progressively metastasizing ependymoma: genomic aberrations.-30 Extradural ependymoma: diagnosis using magnetic resonance imaging.-31 Primary malignant ependymoma of the abdominal cavity: diagnosis.-32 Atypical histologic features and patterns of malignant evolution in tanycytic ependymoma.-33 Intracranial ependymoma: role for chemotherapy. Index.mehr
Kritik
From the reviews:
"This volume in the series, Tumors of the Central Nervous System, explores recent developments in tumor biology and newer classification and treatment information for seven distinct types of brain tumors. ... The book is written for oncologists, both fellows and practitioners, neuro-oncologists, neurologists, neuropathologists, and neurosurgeons. ... In addition to providing an update, the book can also inspire a new generation of researchers in tumor biology and in the design of more effective and scientifically based chemotherapy." (Ramsis Farid Ghaly, Doody's Review Service, October, 2012)mehr

Autor